Risk Factors, Pathological Changes, and Potential Treatment of Diabetes-Associated Cognitive Dysfunction

被引:0
作者
Meng, Xiaoyu [1 ,2 ,3 ]
Du, Haiyang [4 ]
Li, Danpei [1 ,2 ,3 ]
Guo, Yaming [1 ,2 ,3 ]
Luo, Peiqiong [1 ,2 ,3 ]
Pan, Limeng [1 ,2 ,3 ]
Kan, Ranran [1 ,2 ,3 ]
Yu, Peng [1 ,5 ]
Xiang, Yuxi [1 ,2 ,3 ]
Mao, Beibei [1 ,2 ,3 ]
He, Yi [1 ,2 ,3 ]
Wang, Siyi [1 ,2 ,3 ]
Li, Wenjun [6 ]
Yang, Yan [1 ,2 ,3 ]
Yu, Xuefeng [1 ,2 ,3 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med,Div Endocrinol, Wuhan, Peoples R China
[2] Hubei Clin Med Res Ctr Endocrinol & Metab Dis, Wuhan, Hubei, Peoples R China
[3] Branch Natl Clin Res Ctr Metab Dis, Wuhan, Peoples R China
[4] Zhoukou Cent Hosp, Dept Orthopaed, Zhoukou, Peoples R China
[5] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Endocrinol, Wuhan, Peoples R China
[6] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Comp Ctr, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetes; diabetes-associated cognitive dysfunction; pathological changes; potential drug treatment; HIPPOCAMPAL INSULIN-RESISTANCE; BLOOD-BRAIN-BARRIER; A-BETA DEPOSITION; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; INTRANASAL INSULIN; ELDERLY-PATIENTS; APOLIPOPROTEIN-E; OLDER-ADULTS;
D O I
10.1111/1753-0407.70089
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDiabetes is a prevalent public health issue worldwide, and the cognitive dysfunction and subsequent dementia caused by it seriously affect the quality of life of patients.MethodsRecent studies were reviewed to provide a comprehensive summary of the risk factors, pathogenesis, pathological changes and potential drug treatments for diabetes-related cognitive dysfunction (DACD).ResultsSeveral risk factors contribute to DACD, including hyperglycemia, hypoglycemia, blood sugar fluctuations, hyperinsulinemia, aging, and others. Among them, modifiable risk factors for DACD include blood glucose control, physical activity, diet, smoking, and hypertension management, while non-modifiable risk factors include age, genetic predisposition, sex, and duration of diabetes. At the present, the pathogenesis of DACD mainly includes insulin resistance, neuroinflammation, vascular disorders, oxidative stress, and neurotransmitter disorders.ConclusionsIn this review, we provide a comprehensive summary of the risk factors, pathogenesis, pathological changes and potential drug treatments for DACD, providing information from multiple perspectives for its prevention and management.
引用
收藏
页数:35
相关论文
共 329 条
[1]   Endothelin-1 (ET-1) promotes a proinflammatory microglia phenotype in diabetic conditions [J].
Abdul, Yasir ;
Jamil, Sarah ;
He, Lianying ;
Li, Weiguo ;
Ergul, Adviye .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2020, 98 (09) :596-603
[2]   Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study [J].
Abdullah, Zarin ;
Cui, Ying ;
Platt, Robert W. ;
Renoux, Christel ;
Azoulay, Laurent ;
Xia, Chenjie ;
Yu, Oriana Hoi Yun .
BMJ OPEN DIABETES RESEARCH & CARE, 2025, 13 (01)
[3]   Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology [J].
Abner, Erin L. ;
Nelson, Peter T. ;
Kryscio, Richard J. ;
Schmitt, Frederick A. ;
Fardo, David W. ;
Woltjer, Randall L. ;
Cairns, Nigel J. ;
Yu, Lei ;
Dodge, Hiroko H. ;
Xiong, Chengjie ;
Masaki, Kamal ;
Tyas, Suzanne L. ;
Bennett, David A. ;
Schneider, Julie A. ;
Arvanitakis, Zoe .
ALZHEIMERS & DEMENTIA, 2016, 12 (08) :882-889
[4]   Jiawei Shengmai San herbal formula ameliorates diabetic associate cognitive decline by modulatingAKTandCREBin rats [J].
Ahmed, Ayaz ;
Zeng, Guirong ;
Azhar, Mudassar ;
Lin, Haiying ;
Zhang, Mijia ;
Wang, Fengzhong ;
Zhang, Hong ;
Jiang, Dejian ;
Yang, Sijin ;
Farooq, Ahsana Dar ;
Choudhary, Muhammad Iqbal ;
Liu, Xinmin ;
Wang, Qiong .
PHYTOTHERAPY RESEARCH, 2020, 34 (12) :3249-3261
[5]   Risk factors for developing dementia in type 2 diabetes mellitus patients with mild cognitive impairment [J].
Albai, Oana ;
Frandes, Mirela ;
Timar, Romulus ;
Roman, Deiana ;
Timar, Bogdan .
NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2019, 15 :167-175
[6]   Melatonin reverses cognitive deficits in streptozotocin-induced type 1 diabetes in the rat through attenuation of oxidative stress and inflammation [J].
Albazal, Ala ;
Delshad, Alireza-Azizzadeh ;
Roghani, Mehrdad .
JOURNAL OF CHEMICAL NEUROANATOMY, 2021, 112
[7]   Effect of Various Intermittent Fasting Protocols on Hyperglycemia-Induced Cognitive Dysfunction in Rats [J].
Alfheeaid, Hani A. A. ;
Alhowail, Ahmad A. A. ;
Ahmed, Faiyaz ;
Zaki, Abdel Kader A. ;
Alkhaldy, Areej .
BRAIN SCIENCES, 2023, 13 (02)
[8]   Liraglutide Alleviates Cognitive Deficit in db/db Mice: Involvement in Oxidative Stress, Iron Overload, and Ferroptosis [J].
An, Ji-Ren ;
Su, Jia-Nan ;
Sun, Gui-Yan ;
Wang, Qing-Feng ;
Fan, Ya-Dong ;
Jiang, Nan ;
Yang, Yu-Feng ;
Shi, Yan .
NEUROCHEMICAL RESEARCH, 2022, 47 (02) :279-294
[9]   Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses [J].
Antal, Botond ;
McMahon, Liam P. ;
Sultan, Syed Fahad ;
Lithen, Andrew ;
Wexler, Deborah J. ;
Dickerson, Bradford ;
Ratai, Eva-Maria ;
Mujica-Parodi, Lilianne R. .
ELIFE, 2022, 11
[10]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666